🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Krsnaa Diagnostics Limited KRSNAA NSEPHARMA

Healthcare · Diagnostics & Research · India
https://krsnaadiagnostics.com

Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, such as ophthalmic test, mammography, dental imaging, stress test, dual-energy X-ray absorptiometry scan, and bone mineral density test. It serves individual patients, government clients, corporate clients, hospitals, clinics, private practitioner, and other healthcare providers. Krsnaa Diagnostics Limited was incorporated in 2010 and is based in Pune, India.

READ MORE ›
₹549.45
-13.40% 1Y

Market & Price

Market Cap
₹1,782.34 Cr
Current Price
₹549.45
High / Low (52W)
₹866.20 / ₹520.30
Beta
-

Valuation

Stock P/E
17.79
Industry PE
37.60
Forward P/E
12.14
PEG Ratio
-
Book Value
₹284.46
Price to Book
1.93
P/S
2.18
EV/EBITDA
7.66
Dividend Yield
0.50%

Profitability & Returns

ROCE
10.64%
ROE
10.89%
ROA
6.63%
Profit Margin
12.43%
Op Margin
16.77%
EPS (Latest Qtr)
₹12.70
EPS (TTM)
₹30.88

Balance Sheet & Liquidity

Debt/Equity
0.55
Quick Ratio
2.38
Current Ratio
2.68
Debt
₹534.32 Cr
Total Assets
₹1,823.72 Cr
Current Assets
₹738.34 Cr
Working Capital
₹463.14 Cr

Ownership

Promoter Holding
46.74%
Chg in Prom Hold
-
FII / Inst Holding
15.25%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
₹1,956.02 Cr
Total Revenue (TTM)
₹816.16 Cr
EBITDA
₹255.26 Cr
Free Cash Flow
₹-18.70 Cr
Operating Cash Flow
₹143.10 Cr
Shares Outstanding
₹3.24 Cr
Gross Margin
78.06%
Payout Ratio
8.91%

Growth (CAGR)

Revenue 5Y
16.63%
Profit 5Y
17.76%
Revenue (YoY)
3.50%
Earnings (YoY)
102.10%

PROS

  • Compounding revenue at 16.6% over 5 years.
  • Profit CAGR of 17.8% over 5 years.

CONS

  • Trading 36.6% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

NSE TradingView Screener.in

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 KRSNAA Krsnaa Diagnostics Limited NSEPHARMA 549.45 17.79 ₹1,782.34 Cr 0.50% 10.64% 10.89% 16.63% 17.76%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,799.20 37.59 ₹4.32 L Cr 0.92% 17.94% 14.72% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 6,667.00 68.97 ₹1.77 L Cr 0.45% 18.96% 16.19% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,410.80 68.96 ₹1.49 L Cr 0.86% 9.06% 16.98% 13.27% 20.21%
5 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,401.00 29.16 ₹1.13 L Cr 0.93% 14.88% 11.74% 7.23% 11.45%
6 DRREDDY Dr. Reddy's Laboratories Limited NIFTY50NSEAIPHARMA 1,303.50 25.90 ₹1.09 L Cr 0.61% 14.00% 11.83% 10.96% -2.35%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,077.70 21.51 ₹1.08 L Cr 0.09% 19.24% 18.32% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,267.70 19.49 ₹1.04 L Cr 0.53% 28.42% 26.91% 19.10% 131.46%
9 MANKIND Mankind Pharma Limited NIFTY_MIDNSEPHARMA 2,375.60 51.29 ₹98,090.71 Cr 0.08% 13.78% 12.45% 17.73% 14.28%
⚙Ad space

Quarterly Results

Figures in INR.

Metric Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue -174.51 Cr186.08 Cr192.98 Cr205.99 Cr181.20 Cr192.60 Cr
Cost of Revenue -53.47 Cr58.95 Cr62.79 Cr65.14 Cr54.14 Cr58.68 Cr
Gross Profit -121.04 Cr127.12 Cr130.19 Cr140.85 Cr127.06 Cr133.93 Cr
Operating Expenses -98.66 Cr96.09 Cr100.42 Cr105.28 Cr103.28 Cr101.64 Cr
Operating Income -22.37 Cr31.03 Cr29.76 Cr35.57 Cr23.79 Cr32.29 Cr
EBITDA -54.31 Cr57.37 Cr55.35 Cr63.34 Cr50.13 Cr86.37 Cr
Interest Expense -6.13 Cr6.81 Cr6.30 Cr8.19 Cr7.79 Cr12.08 Cr
Pretax Income -25.48 Cr28.61 Cr27.42 Cr31.56 Cr19.68 Cr51.70 Cr
Tax Provision -6.06 Cr7.93 Cr6.90 Cr7.62 Cr4.44 Cr9.98 Cr
Net Income -19.41 Cr20.68 Cr20.52 Cr23.95 Cr15.25 Cr41.72 Cr
Diluted EPS 5.925.886.286.257.254.6612.70

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue -487.12 Cr619.63 Cr717.16 Cr772.77 Cr
Cost of Revenue -155.39 Cr206.51 Cr229.94 Cr240.75 Cr
Gross Profit -331.74 Cr413.12 Cr487.22 Cr532.02 Cr
Operating Expenses -262.50 Cr343.37 Cr385.42 Cr410.61 Cr
Operating Income -69.24 Cr69.75 Cr101.80 Cr121.41 Cr
EBITDA -140.42 Cr158.64 Cr215.66 Cr255.19 Cr
Interest Expense -6.43 Cr14.09 Cr24.65 Cr34.36 Cr
Pretax Income -80.20 Cr70.01 Cr102.69 Cr130.37 Cr
Tax Provision -18.09 Cr13.17 Cr25.08 Cr28.94 Cr
Net Income -62.11 Cr56.84 Cr77.61 Cr101.43 Cr
Diluted EPS -19.2917.3123.5630.88

Compounded Sales Growth

5 Years:16.63%
1 Year:3.50%

Compounded Profit Growth

5 Years:17.76%
1 Year:102.10%

Stock Price Performance

1 Year:-13.40%
6 Months:-30.99%
3 Months:-13.87%
1 Month:-5.42%

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -909.89 Cr1,171.91 Cr1,281.60 Cr1,823.72 Cr
Current Assets -222.91 Cr421.19 Cr414.47 Cr738.34 Cr
Cash & Equivalents -22.72 Cr2.38 Cr3.85 Cr30.22 Cr
Inventory -25.07 Cr35.81 Cr29.48 Cr26.66 Cr
Receivables -73.10 Cr176.29 Cr277.75 Cr295.51 Cr
Total Liabilities -171.16 Cr362.11 Cr398.82 Cr843.33 Cr
Current Liabilities -99.19 Cr281.47 Cr305.39 Cr275.20 Cr
Long Term Debt -11.00 Cr5.50 Cr18.50 Cr437.14 Cr
Total Debt -32.48 Cr159.79 Cr203.53 Cr534.32 Cr
Total Equity -738.74 Cr809.80 Cr882.77 Cr980.39 Cr
Shares Outstanding -3.14 Cr3.23 Cr3.23 Cr3.24 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -76.30 Cr24.34 Cr87.33 Cr143.10 Cr
Investing Cash Flow --108.89 Cr-128.88 Cr-99.61 Cr-395.99 Cr
Financing Cash Flow --33.15 Cr84.19 Cr13.75 Cr279.26 Cr
Capital Expenditure --141.36 Cr-193.89 Cr-126.63 Cr-219.26 Cr
Free Cash Flow --65.06 Cr-169.54 Cr-39.30 Cr-76.16 Cr
Net Change in Cash --65.73 Cr-20.34 Cr1.47 Cr26.38 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -68.1%66.7%67.9%68.8%
Operating Margin % -14.2%11.3%14.2%15.7%
Net Margin % -12.8%9.2%10.8%13.1%
ROE % -8.4%7.0%8.8%10.3%
ROCE % -8.5%7.8%10.4%7.8%

Shareholding Pattern

Insiders
46.74%
Institutions
15.25%
Public Float
28.64%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for KRSNAA

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space